- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06828406
Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor (I'M SPEAKING)
February 1, 2026 updated by: Ann Borders, Endeavor Health
Improving Safety, Patient Experience, and Equity Through Shared Decision-making Huddles in Labor (I'M SPEAKING)
To evaluate the effectiveness of an existing quality improvement (QI) training program known as TeamBirth, using a randomized stepped-wedge hybrid type II study design, to (a) decrease nulliparous term singleton vertex (NTSV) cesarean birth (CB) across all birthing people, and specifically for Black birthing people, and (b) increase shared decision-making (SDM), (c) improve patient experience of respectful care.
TeamBirth uses a train-the-trainer model to implement patient-participatory shared decision-making on Labor and Delivery (L&D) units, with the goal of decreasing unwanted and unnecessary interventions and improving patient experiences and outcomes for labor and birth.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
2200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Constandina Kapogiannis
- Phone Number: 847-570-2832
- Email: constandina.kapogiannispolitis@endeavorhealth.org
Study Locations
-
-
Illinois
-
Evanston, Illinois, United States, 60201
- Recruiting
- Endeavor Health Evanston Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age 18 or older
- English or Spanish speaking
- Gave birth to a live-born infant after laboring
Exclusion Criteria:
- Speaks a language other than English or Spanish
- Under the age of 18
- Gave birth to a nonliving infant
- Cesarean delivery without labor
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual Care
|
|
|
Other: Intervention TeamBirth
shared decision making in labor using team huddles
|
TeamBirth
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nulliparous Term Singleton Vertex (NTSV) Cesarean Birth (CB)
Time Frame: 6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
NTSV CB Rate for all birthing people in participating hospitals
|
6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
|
Shared Decision Making (SDM)
Time Frame: 6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
Childbirth Options, Information, and Person-Centered Explanation (CHOICEs) scale, scores range from 14 to 90, high scores indicate higher levels of shared decision making
|
6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
NTSV CB in Black birthing people
Time Frame: 6 months prior to TeamBirth , 3 months post TeamBirth implementation
|
NTSV CB Rate Black birthing people in participating hospitals
|
6 months prior to TeamBirth , 3 months post TeamBirth implementation
|
|
SDM in Black birthing people
Time Frame: 6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
Childbirth Options, Information, and Person-Centered Explanation (CHOICEs) scale, scores range from 14 to 90, high scores indicate higher levels of shared decision making
|
6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
|
Patient Experience
Time Frame: 6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
Illinois Perinatal Quality Collaborative (ILPQC) Patient-Reported Experience Measure (PREM), there is no numerical value assigned to the ILPQC PREM
|
6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
|
Patient Experience
Time Frame: 6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
Mother's Autonomy in Decision Making (MADM), scores range from 7 to 42, higher scores indicate the women had greater agency and autonomy when engaging in a shared decision making process with a maternity care provider
|
6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
|
Patient Experience
Time Frame: 6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
Person-Centered Maternity Care Scale for use in the United States (PCMC-US), scores range from 0 to 100, higher scores indicate more person-centered maternity care
|
6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
|
Patient Experience
Time Frame: 6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
CollaboRATE, scores range from 0 to 100, a higher score means the number of core dimensions of shared decision making are met
|
6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
|
Patient Experience
Time Frame: 6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
Acceptability of Intervention Measure (AIM), scores range from 3 to 15, the lower the score, the more satisfied the patient was with their care
|
6 months prior to TeamBirth, 3 months post TeamBirth implementation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ann Borders, Endeavor Health
- Principal Investigator: Beth Plunkett, Endeavor Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 29, 2025
Primary Completion (Estimated)
October 31, 2027
Study Completion (Estimated)
July 1, 2029
Study Registration Dates
First Submitted
December 5, 2024
First Submitted That Met QC Criteria
February 10, 2025
First Posted (Actual)
February 14, 2025
Study Record Updates
Last Update Posted (Actual)
February 3, 2026
Last Update Submitted That Met QC Criteria
February 1, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Study00000033
- BPS-2023C2-33453 (Other Grant/Funding Number: Patient Centered Outcomes Research Institute (PCORI))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Data to be banked may include:
- De-identified transcripts of clinician, birthing person, partner/support person focus groups or interviews
- De-identified ethnographic field notes
- De-identified birthing person, partner/support person survey data
- De-identified administrative data on birth outcomes for Illinois hospitals
IPD Sharing Time Frame
7 years post completion of the final research report.
We anticipate the final research report to be completed 7/1/2030.
IPD Sharing Access Criteria
Data collected from this study will be de-identified and banked for further use as required by the funder's Policy for Data Management and Data Sharing policy accessible here: https://www.pcori.org/about/governance/pcoris-policy-data-management-and-data-sharing.
According to the funder's policy, the full de-identified, cleaned dataset must be maintained for at least 7 years following completion of the final research report to the funder.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Perinatal Decision Making
-
Massachusetts General HospitalUnknownDecision Making | Video Decision AidsUnited States
-
Boston CollegeCompleted
-
Instituto Tecnologico y de Estudios Superiores...Completed
-
Brigham and Women's HospitalCompleted
-
University of ZurichPfizerCompletedDecision MakingSwitzerland
-
University Hospital, Clermont-FerrandCompleted
-
Umraniye Education and Research HospitalCompleted
-
University of UtahNational Institutes of Health (NIH)Completed
-
Rush University Medical CenterNot yet recruiting
-
University of California, San FranciscoNot yet recruitingDiagnostic Decision Making
Clinical Trials on TeamBirth
-
Karolinska InstitutetVärmland County Council, Sweden; Region Skane; Region Stockholm; Uppsala University... and other collaboratorsRecruitingPatient Satisfaction | Patient Safety | Person Centered CareSweden